Myelofibrosis Models: Literature Review and Own Data by AA Silyutina, II Gin, NM Matyukhina, EN Balayan, PA Butylin

Get full text

Pro- and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders by AA Silyutina, NM Matyukhina, EG Lisina, VI Khvan, SN Leleko, NT Siordiya, OV Sirotkina, PA Butylin

Get full text

Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia by VV Strugov, EA Stadnik, AM Rumyantsev, TO Andreeva, YuV Virts, YuV Mirolyubova, PA Butylin, AYu Zaritskey

Get full text

Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia by YuV Mirolyubova, EA Stadnik, VV Strugov, TO Andreeva, TS Nikulina, YuV Virts, PA Butylin, AG Rumyantsev, AYu Zaritskey

Get full text

Manufacturing of CD19 Specific CAR T-Cells and Evaluation of their Functional Activity in Vitro by AV Petukhov, VA Markova, DV Motorin, AK Titov, NS Belozerova, PM Gershovich, AV Karabel’skii, RA Ivanov, EK Zaikova, EYu Smirnov, PA Butylin, AYu Zaritskey

Get full text